Randomized trials for the treatment of burning mouth syndrome: an evidence-based review of the literature

Journal of Oral Pathology & Medicine, 05/04/2012

Therapies that used capsaicin, alpha–lipoic acid (ALA), and clonazepam were those that showed more reduction in symptoms of Burning mouth syndrome (BMS). However, many studies of therapeutic interventions in BMS lack consistency in their results, because they use in their methodology, sample and a relatively short time of therapy and often do not provide a follow–up of patients treated.

Print Article Summary Cat 2 CME Report